SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001864317-23-000001
Filing Date
2023-09-26
Accepted
2023-09-26 18:01:28
Documents
1
Period of Report
2023-09-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3598
  Complete submission text file 0001864317-23-000001.txt   4946
Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Issuer) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address 201 SHIPYARD WAY NEWPORT BEACH CA 92663
Business Address
Katzoff David J (Reporting) CIK: 0001864317 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40483 | Film No.: 231281447